Value through Innovation27 July 2016

Clinical Study Results

  • ATROVENT ® - Common Cold
    Clinical Study Number 244.2503
    Study Indication Common Cold
    Product ATROVENT ®
    Generic Name Ipratropium bromide
    Lab Code
    Clinical Phase IIIb/IV
    Study Title

    A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) with Rhinorrhea Associated with a Common Cold or Allergy

    Study Document Trial synopsis 244.2503_CO english
  • MUCOVIRAL ® - Common Cold
    Clinical Study Number 1326.1
    Study Indication Common Cold
    Product MUCOVIRAL ®
    Generic Name Carrageenan
    Lab Code
    Clinical Phase IV
    Study Title

    Efficacy and safety of Iota-Carrageenan nasal spray 1.2 g/l (0.12%) (Bisolviral®) versus placebo nasal spray in the early treatment of common cold

    Study Document Trial synopsis 1326.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.